AXL and renal cell carcinoma: In addition, overexpression of AXL has been implicated in the development and progression of numerous malignancies; furthermore, AXL has been identified as a predictor of poor patient outcome in lung, breast, and pancreatic cancer, renal cell carcinoma, and glioblastoma [9, 14–23].